Tag: NASDAQ:SGMO

What is In-Licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?

Sangamo to Present Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data

The company will present data at the 61st Annual Meeting of the American Society of Hematology in Orlando, Florida between...